Literature DB >> 29371316

The management of lupus in young people.

George McGill1, Nicola Ambrose2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29371316      PMCID： PMC5774960          DOI： 10.3399/bjgp18X694805

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  5 in total

1.  European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.

Authors:  Noortje Groot; Nienke de Graeff; Tadej Avcin; Brigitte Bader-Meunier; Paul Brogan; Pavla Dolezalova; Brian Feldman; Isabelle Kone-Paut; Pekka Lahdenne; Stephen D Marks; Liza McCann; Seza Ozen; Clarissa Pilkington; Angelo Ravelli; Annet van Royen-Kerkhof; Yosef Uziel; Bas Vastert; Nico Wulffraat; Sylvia Kamphuis; Michael W Beresford
Journal:  Ann Rheum Dis       Date:  2017-06-19       Impact factor: 19.103

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Management of pregnancy in systemic lupus erythematosus.

Authors:  Aisha Lateef; Michelle Petri
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 4.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093

5.  Differences in disease phenotype and severity in SLE across age groups.

Authors:  N Ambrose; T A Morgan; J Galloway; Y Ionnoau; M W Beresford; D A Isenberg
Journal:  Lupus       Date:  2016-05-04       Impact factor: 2.911
  5 in total
  2 in total

1.  Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine.

Authors:  Andrew J Lotery; Imran H Yusuf
Journal:  Br J Gen Pract       Date:  2018-03       Impact factor: 5.386

Review 2.  B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.

Authors:  Meredyth G Ll Wilkinson; Elizabeth C Rosser
Journal:  Front Immunol       Date:  2019-02-14       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.